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Policy, environmental, and systems-level interventions 
are part of a comprehensive approach to managing high 
blood pressure and high cholesterol, which are key risk 
factors for heart disease and stroke. In this qualitative 
case study, we identified clinical practices in health care 
organizations that used policy, environmental, or sys-
tems-level interventions to improve patient outcomes 
for these conditions. Our 4 objectives were to describe 1) 
policy, environmental, and systems-level interventions; 2) 
enabling factors and barriers that affected implementa-
tion; 3) methods for evaluating the success of the interven-
tion; and 4) lessons learned from the health care practices 
that implemented these interventions.
Methods
Through literature review and expert guidance, we 
identified 34 health care practices that used policy, envi-
ronmental, and systems-level interventions to manage 
high blood pressure and high cholesterol. In 2003, we 
conducted case study interviews with key informants for 
9 health care practices that 1) demonstrated improved 
patient outcomes for blood pressure or cholesterol; 2) 
implemented the interventions for at least 1 year; and 3) 
remained committed to sustaining or institutionalizing 
interventions. We taped and transcribed the interviews 
and used Centers for Disease Control and Promotion EZ-
Text software (www.cdc.gov/hiv/software/ez-text.htm) to 
code, categorize, and analyze the responses.
Results
The health care practices we studied implemented 
specialized lipid clinics, disease management programs, 
physician reminder systems, and participation in the 
Health Resources and Services Administration’s Bureau 
of Primary Care Health Disparities Collaboratives. All 
practices used comprehensive systems for patient care 
that were well-defined, measurable, and linked to desir-
able patient outcomes. Most relied on data systems to 
identify patients targeted for the interventions and prac-
tice areas that needed improvement, and to track the 
progress of patients and practitioners in meeting goals. 
Factors contributing to success included support for 
patient self-management, interventions integrated into 
the practice’s daily work flow to make implementation 
easier for staff, leadership and staff commitment, and 
community involvement.
Conclusion
Comprehensive policy, environmental, and systems-
level interventions for patient care can be effective in 
controlling chronic conditions such as high blood pressure 
and high cholesterol.
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Introduction
Coronary heart disease and stroke are the first and third 
leading causes of death in the United States (1) and major 
causes of disability (1,2). The American Heart Association 
and the American Stroke Association estimate that the 
total direct and indirect cost of cardiovascular disease 
(CVD) in the United States in 2007 was $438 billion (2). 
Much of the burden of heart disease and stroke could be 
eliminated by preventing or reducing 7 major risk factors 
— high blood pressure, high cholesterol, obesity, tobacco 
use, diabetes, physical inactivity, and poor diet (3,4). For 
example, a reduction in systolic blood pressure of 12 to 13 
mm Hg over 4 years of follow-up can reduce heart attacks 
by 21%, strokes by 37%, and all deaths from coronary 
vascular disease by 25% (5). Furthermore, a 10% decrease 
in total cholesterol may reduce the incidence of coronary 
heart disease by as much as 30% (6,7). However, only an 
estimated 31% of adults with high blood pressure (8) and 
18% of those with high cholesterol (9) have these condi-
tions under control. The 2004 estimated prevalence of high 
blood pressure at or above 140/90 mm Hg in U.S. adults 
aged 20 and older was 33.6%, and total cholesterol at or 
above 200 mg/dL was 48.4% (2). The Healthy People 2010 
targets are to reduce the proportion of adults with high 
blood pressure to 16% and to lower the proportion of adults 
with elevated total cholesterol to 17% (10).
Why is it such a challenge to prevent and control high 
blood pressure and high cholesterol? The literature cites 
many reasons (11-15). Some articles focus on patient-
related factors, such as noncompliance with treatment 
regimens because of medication side effects, complexity 
of the drug regimen(s), and lack of awareness of the need 
for long-term therapy (11-13). Others focus on the failure 
of physicians to consistently comply with evidence-based 
guidelines (14). According to Wagner, Austin, and Von 
Korff, clinical practices are not structured to adequately 
care for patients with chronic conditions (15):
Medical practices, especially those in primary care, 
are generally organized to respond to the acute 
and urgent needs of their patients, or symptom-
relieving treatments. . . . This leaves little time or 
intellectual energy for addressing the less urgent, 
but nevertheless predictable, needs of patients 
with chronic illness in managing their conditions 
and preventing deleterious sequelae.
Policy, environmental, and systems-level (PES) interven-
tions constitute a paradigm shift in clinical care from ear-
lier health care models and represent an ecological model 
that links PES changes with behavior changes at the indi-
vidual level to prevent heart disease and stroke (16-18). 
Policy interventions include laws, regulations, and formal 
and informal rules adopted within specific organizations 
(19). For example, health care organizations can have 
treatment policies to implement evidence-based national 
clinical guidelines such as those of the Seventh Report of 
the Joint National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure (JNC 
7) (20); the Third Report of the Expert Panel on Detection, 
Evaluation, and Treatment of High Blood Cholesterol in 
Adults (ATP III Final Report) (21); and the 2002 update 
to the American Heart Association (AHA) guidelines (22) 
and the 2001 update to the  AHA/American College of 
Cardiology guidelines (23).
Environmental interventions are changes to the econom-
ic, social, or physical environments (19). Examples include 
making community resources available and known to the 
public and creating an environment that allows people to 
make healthier choices.
Systems-level interventions are changes affecting the 
way an organizational system operates. Within the health 
care setting, these interventions generally focus on chang-
ing the ways in which health services are delivered and 
may include delegating responsibility for key care func-
tions to nonphysician members of the health care practice, 
putting systems in place to ensure appropriate follow-up 
with patients, and providing regular feedback to physicians 
on how well they manage their patients’ conditions (24).
A 1996 literature review (15) examined comprehensive 
approaches to reorganizing the delivery of care to improve 
the outcomes of patients with chronic illness. The review’s 
authors noted that successful interventions shared the 
following elements: 1) explicit protocols based on evidence-
based guidelines; 2) practice organization to meet the 
needs of patients who require more time, a broad array of 
resources, and closer follow-up; 3) systematic attention to 
providing patients with information for behavioral change; 
4) ready access to necessary expertise; and 5) supportive 
information systems (15). These elements, which also 
could be considered PES interventions, are reflected in 
Edward H. Wagner’s Chronic Care Model (25). This model 
for improving the care of patients with chronic disease has 
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essential elements grouped in 6 areas: 1) the community 
(resources and policies), 2) the health care system (organi-
zation of health care), 3) support for patient self-manage-
ment, 4) design for delivering health services to patients, 
5) support for physician decisions, and 6) clinical informa-
tion systems.
In a 1997 review of interventions to prevent cardiopul-
monary disorders among patients in health care settings, 
Ockene et al (26), concluded that traditional education 
and training programs for health care providers combined 
with reminders systems, feedback to providers, and prac-
tice guidelines are most effective for delivering preventive 
interventions. They also found that the effectiveness of 
providers is optimized when the intervention uses a team 
of both nonphysicians and physicians to counsel patients 
on prevention and when providers support the control 
of risk factors through multiple patient visits, follow-up 
telephone calls to the patient, or referrals to specialists as 
appropriate.
We have identified other promising quasi- 
experimental or experimental studies published from 
1997 through 2007 describing interventions in health 
care settings that contribute to preventing and control-
ling high blood pressure, high cholesterol, heart disease, 
and stroke (14,20-23,27-72). Elements of interventions 
that showed improvement in outcomes for high blood 
pressure or high cholesterol included 1) providers that 
adhere to standardized protocols that are consistent 
with evidence-based national guidelines (20-23,28-44); 
2) multidisciplinary clinical care teams that deliver 
elements of quality patient care, such as routine and con-
sistent screening, assessment, counseling, and patient 
follow-up contacts, to control risk factors (32,33,38,45-
48); 3) treatment and prevention clinics that deliver 
focused management of care (31,33-37,49-54); 4) elec-
tronic medical record systems, automatic prescription 
systems, and paper and electronic reminder systems 
for health care providers (14,55-63); and 5) patient 
education (61,62,65-71). National treatment guidelines 
recommend that clinical prevention and treatment 
 services include these 5 elements (54,55,58,59,63,64, 
68,71).
Purpose of study 
The purpose of our case study was to identify and 
describe promising health care practices (PHPs) and the 
PES interventions these practices used to control high 
blood pressure and high cholesterol. We defined a PHP 
as one that had practice-based data showing positive out-
comes from interventions to reduce risk factors related to 
heart disease and stroke but whose data may not yet have 
been tested in controlled studies to allow for generalizable 
results (16). We also identified the strategies that led to 
successful adoption and implementation of these PES 
interventions, the methods used to evaluate progress, and 
lessons learned.
Methods
We searched peer-reviewed literature databases (ABI/
Inform, Ann Arbor, Michigan; Lexis/Nexis, New York, 
New York; OVID, New York, New York; and the National 
Library of Medicine’s PubMed, Bethesda, Maryland) for 
articles published from 1992 through 2003 to identify 
studies of PES interventions in health care settings that 
were focused on the prevention of heart disease and 
stroke. We also used Google (www.google.com) to iden-
tify practices implementing PES interventions that had 
received special recognition, such as the C. Everett Koop 
award for exemplary health care programs. In addition, 
we selected a variety of experts from among participants 
in national conferences and our own professional con-
tacts, including staff from state health departments, rep-
resentatives from business groups and health associa-
tions, and researchers, to identify PHPs that were using 
PES interventions. The search generated 644 studies of 
PHPs that used PES interventions. We narrowed the 
list to 34 studies that reported all 3 of the following: 
1) data on improved patient outcomes in the control 
of blood pressure (<140/90 mm Hg) and cholesterol 
(<200 mm/dL for total cholesterol or <100 mg/dL for 
low-density lipoprotein cholesterol [LDL]), 2) incorpora-
tion of the interventions for at least 1 year, and 3) organi-
zational commitment to sustaining or institutionalizing 
the interventions. We made initial phone calls to gather 
information if it was not publicly available and then used 
the following criteria to rank and select 9 of the 34 PHPs: 
1) use of a control or comparison group in the study, 2) 
outcomes that were statistically or clinically significant, 
3) incorporation of national JNC 7 (20) and ATP III (21) 
guidelines, and 4) study populations that were at high 
risk for heart disease and stroke. Using in-depth tele-
phone interviews, we conducted a case study with key 
informants (physicians, other health-care practitioners, 
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and administrators) of the 9 PHPs selected in order to 
identify and learn about the factors and strategies that 
worked for establishing the PES interventions (73). The 
Centers for Disease Control and Prevention (CDC) taped 
and transcribed the interviews and used CDC EZ-Text 
software (provided free at www.cdc.gov/hiv/software/ez-
text.htm) to code, categorize, and analyze responses to the 
interviews.
The 9 PHPs were the Laurel Health System’s CVD 
Collaborative (Wellsboro, Pennsylvania); Health 
Management Corporation (Richmond, Virginia) for Blue 
Cross Blue Shield (BCBS) of Delaware (Wilmington, 
Delaware); Kaiser Permanente (Cleveland, Ohio); Mayo 
Clinic’s Division of Community Internal Medicine 
(Rochester, Minnesota); Robeson Healthcare Corporation’s 
CVD Collaborative (Lumberton, North Carolina); Midwest 
Heart Specialists (Chicago and Rockford, Illinois); MVP 
Health Care (Schenectady, New York, and Williston, 
Vermont); Drug Therapy Management, Inc (Pharmacist-
Managed Lipid Clinic, Greensboro, North Carolina); and 
Partners for Better Health of Health Partners (Minneapolis, 
Minnesota).
Results
The Table summarizes the PES interventions imple-
mented in each of the 9 PHPs included in our study, and 
we describe the study design and reported patient out-
comes in the Appendix. Four of the practices also reported 
their outcome data for high blood pressure and high 
cholesterol control in 5 studies in peer-reviewed journals 
(32,33,54,55,64). 
Key informants described the interventions in their 
PHPs, including 1) factors leading to their implementa-
tion, 2) models used in their design, 3) patient outcomes, 4) 
strategies for measuring progress, 5) costs, and 6) lessons 
learned.
Factors leading to interventions 
The primary reasons PHPs gave for implementing 
the interventions were the realization and concern that 
patients’ lipid concentrations (especially LDL cholesterol) 
or blood pressures were not adequately controlled, as 
judged by using national guidelines (e.g., JNC 7 [20], ATP 
III [21]), and that the compliance of practice providers with 
these guidelines was inconsistent. This realization often 
stemmed from reviewing patient charts and evaluating 
the way health care was delivered within the informants’ 
organizations. Key informants reported that some practi-
tioners admitted that before they analyzed their patient 
charts, they had believed they were adequately following 
guidelines to help patients manage their conditions and 
were surprised to find they were not.
Some key informants said the frequent diagnoses of 
heart disease within their patient population and the 
related costly procedures led their organization to imple-
ment PES interventions. Other informants said they 
were influenced by data in the literature reporting on the 
U.S. burden of heart disease and the positive outcomes 
from PES interventions, particularly for reducing risk 
factors such as high cholesterol and high blood pressure. 
Informants from 2 PHPs mentioned that their decision 
to implement interventions was influenced by changes 
in the health care commercial market, particularly the 
move toward managed care, combined with their need to 
stay competitive. Practitioners in some PHPs introduced 
interventions that would help them more efficiently man-
age CVD in patients without adversely affecting the time 
spent on other responsibilities. Communities were the 
impetus behind some of the interventions. For example, a 
community group in Pennsylvania identified diabetes and 
CVD as major health problems in its community; because 
of the group’s commitment to reducing the impact of these 
diseases in the community, it worked with the Laurel 
Health System to spearhead and move its diabetes and 
cardiovascular collaboratives forward.
Descriptions of the interventions 
Key informants described a wide array of PES interven-
tions that had been implemented in their organizations, 
all of which were based on nationally recognized guidelines 
and best practices. The primary types of interventions 
implemented were automated physician reminder sys-
tems, specialized lipid clinics, collaboratives, and disease 
management programs (described below). The goals of the 
interventions centered on providing physicians with the 
tools to adequately treat patients with high blood pressure 
or high cholesterol, empowering patients with the skills to 
manage their conditions, achieving the goals referenced in 
the national guidelines, and, ultimately, preventing com-
plications related to CVD.
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Automated physician reminder systems integrated 
into electronic medical records
Kaiser Permanente, Ohio, integrated physician remind-
ers into its electronic medical records system to support 
physician decision making at the time of each patient visit. 
This made it easier for physicians to access patient data 
during the visit, to be alerted when a patient’s cholesterol 
or blood pressure was uncontrolled, to determine when 
testing for lipids or other purposes should be performed, 
and to adjust medications as needed.
Specialized lipid clinics 
Two PHPs used specialized lipid clinics to manage their 
patients’ cholesterol and triglyceride values. Lipid clinics 
provide patient-focused care to educate patients and to 
assist them in setting self-management goals for changes 
in lifestyle. In addition, these clinics track patient status 
as measured by cholesterol values, medications prescribed, 
patient compliance with medication regimens, follow-up 
visits, and other factors that determine whether com-
prehensive care is being offered. Some clinics also adjust 
medications based on evidence-based algorithms and the 
approval of the physician. Midwest Heart Specialists 
established a physician-directed lipid clinic that nurses 
managed for some patients with high cholesterol. The 
results of this lipid clinic were so impressive (54) that the 
practice developed a virtual lipid clinic accessible to all 
providers that incorporated the process used in the nurse-
managed clinic into an electronic record system with a 
cholesterol management tool (55). The development of the 
virtual lipid clinic enabled patients from throughout the 
practice to benefit from this intervention. Drug Therapy 
Management, Inc, a pharmacist-managed lipid clinic con-
tracted with a cardiology clinic, also reported successful 
patient outcomes (33).
Collaboratives 
A collaborative is an integrated and collaborative nation-
al effort to eliminate disparities and improve health care 
delivery systems. Collaboratives are designed to help 
health care organizations improve the care of their patients 
with CVD and other chronic diseases. Collaboratives pro-
mote evidence-based health care strategies for quality 
improvement based on the Chronic Care Model and on 
the Plan-Do-Study-Act (PDSA) cycles described below 
(74). They also emphasize sharing experiences among 
participating organizations to enable them to learn from 
one another. Three PHPs participated in a collaborative. 
Mayo Clinic’s Division of Community Internal Medicine 
in Minnesota participated in a collaborative sponsored 
by the Institute for Clinical Systems Improvement (ICSI) 
(www.icsi.org/). As part of this collaborative, this PHP 
implemented the ICSI Guidelines (75) for blood pres-
sure control, which are based on JNC-VI guidelines 
(76), and redesigned the system by which nurses and 
medical assistants screened and managed patient blood 
pressure. Robeson Healthcare Corporation and Laurel 
Health System implemented the Prevention of Diabetic 
and Cardiovascular Disease Collaborative of the Health 
Resources and Services Administration’s (HRSA’s) Bureau 
of Primary Care Health Disparities Collaboratives (www.
healthdisparities.net/hdc/html/collaborativesOverview.
aspx).
Disease management programs 
Three PHPs (Partners for Better Health of Health 
Partners, MVP Health Care, Health Management 
Corporation/BCBS of Delaware) described their disease 
management programs for proactive, comprehensive man-
agement of their patients with CVD. Disease manage-
ment programs, which are disease-specific, provide care 
by using such strategies as population identification pro-
cesses, evidence-based practice guidelines, collaborative 
practice models that include both physicians and providers 
of support services, patient self-management and educa-
tion, measurements of process and outcomes, evaluation 
and management, and routine reporting and feedback 
loops (77).
Health models used for designing interventions 
Four of the 9 PHPs incorporated the Chronic Care Model 
along with PDSA cycles for quality improvement when 
designing their PES interventions. PDSA cycles rely on 
simple measurements to monitor the effect of small chang-
es over time, which then can build into larger improve-
ments through successive quick cycles of change. Although 
informants for the other 5 PHPs did not explicitly mention 
using the Chronic Care Model, their interventions often 
contained some of this model’s elements, such as use of 
protocols based on evidence-based guidelines, reorganiza-
tion of health care delivery, use of clinical information 
systems, and support for patient self-management.
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Two PHPs (Partners for Better Health of Health Partners 
and Health Management Corporation/BCBS of Delaware) 
modeled their patient support components according to 
where patients were on the health continuum:
One model that we’ve used is a model of the health 
continuum [that] describes what we’re trying to do 
with health improvement, and it goes from keeping 
people from advancing into stages of disease. So we 
look at our programs from primary prevention all 
the way through the care of the [patient] population 
with the highest risk and mortality. (informant, 
Partners for Better Health of Health Partners)
Such a model is patient-focused and approaches health 
promotion and prevention of risk factors at all stages of 
disease. Along these lines, some PHPs used nurses to 
regularly interact with patients via telephone or other 
avenues to offer education and support.
Some interventions were modeled after existing pro-
grams that had proven successful. For example, MVP 
Health Care implemented a CVD management program 
patterned after other programs already in place for its 
patients with asthma and diabetes.
Patient outcome data 
Patient outcome data for these PES interventions are 
limited to responses from the interviews with key infor-
mants (see Appendix) and the 5 studies reported in peer-
reviewed journals (32,33,54,55,64). Informants from all 
PHPs reported that their interventions were very success-
ful at increasing providers’ compliance with guidelines 
and in increasing the percentage of patients who met 
their cholesterol or blood pressure goals, complied with 
medication regimens, or set and achieved goals for self-
management. Informants also reported improvements in 
the delivery of health care, which led to an increase in the 
consistency and quality of patient care and more produc-
tive use of providers’ time. Some informants reported that 
these improvements decreased utilization of various forms 
of health care, such as inpatient admissions and emer-
gency room visits, and resulted in significant cost savings 
to health care plans.
Measuring progress 
Informants from the PHPs noted that they measured 
varying combinations of outcomes and processes for qual-
ity improvement. The indicators that the programs used 
to measure the various PES interventions are described 
below. Many informants stated that the organization must 
first agree on its definition of success:
Critical in our start was that we had to come to a 
common definition of success . . . not only [to] define 
success but also [to] measure success. And that was 
coming to agreement on the different . . . outcomes 
measures, process measures, and end results that 
would define our success for everyone. So that 
we were all . . . going after the same goals. (infor-
mant, Health Management Corporation/BCBS of 
Delaware)
Outcomes measures 
Among the patient outcome measures PHPs reported 
were monitoring control of lipids, glucose, and blood 
pressure among patients at risk and patients achieving 
self-management goals, such as weight loss, smoking 
cessation, and participation in regular exercise. Some 
PHPs also evaluated use of aspirin, angiotensin-convert-
ing enzyme inhibitors, and beta-blockers in patients with 
heart disease. Many PHPs also measured utilization rates 
for health care, such as emergency room visits, hospitaliza-
tions, and the pharmacy. In addition, Partners for Better 
Health of Health Partners monitored the percentage of 
patients who had all modifiable risk factors managed 
optimally. Drug Therapy Management, Inc, monitored the 
number of recurrent cardiovascular events, and Midwest 
Heart Specialists calculated the number of cardiovascular 
events prevented or lives saved.
Process measures 
Process measures included measuring physicians’ com-
pliance with policies and guidelines, patients’ compliance 
with medications and plans of care, and the percentage 
of patients screened for abnormal lipids, blood pressure, 
glucose, and glycosylated hemoglobin. PHPs that incorpo-
rated PDSA cycles conducted mini-studies to evaluate the 
effectiveness of each step of the intervention. For example, 
as part of redesigning the way it delivered patient care, 
Mayo Clinic delegated responsibility to licensed practical 
nurses (LPNs) and medical assistants (MAs) for taking 
patients’ blood pressure and referring patients with ele-
vated values for a follow-up visit with a registered nurse. 
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Before delegating this responsibility to the LPNs and 
MAs, the clinic first monitored the number of times the 
LPN or MA successfully recognized high blood pressure 
and made the referral.
Choosing measures 
Informants for some PHPs explained how they chose 
measures and why they chose to evaluate certain ones. 
They chose measures they believed would help them 
improve the quality of care for patients, decrease expenses, 
or have the most impact on health outcomes. Often they 
chose to evaluate measures to help them comply with stan-
dards set by organizations such as the National Committee 
for Quality Assurance, HRSA’s Bureau of Primary Health 
Care, or the National Cholesterol Education Program.
We felt that we could make the most impact on the 
lipid profile, so we chose the lipid one [as an option-
al parameter to measure]. (informant, Robeson 
Healthcare Corporation)
Information systems 
Most PHPs used information technology systems to con-
tinuously monitor selected measures and to provide regu-
lar feedback to health care practitioners, organization 
management, or HRSA’s Bureau of Primary Health Care 
(Health Disparities Collaboratives). The feedback showed 
areas in need of improvement and indicated whether 
goals were achieved. The PHPs subsequently used the 
feedback to improve various components of the interven-
tion. One PHP informant described the use of statistical 
process control (SPC) to evaluate which processes needed 
improvement:
Using SPC, you could tell if some of the measures 
were basically more than 2 standard deviations 
from the desired goal. In which case, in SPC ter-
minology, that means you need to change your pro-
cesses. (informant, Kaiser Permanente, Ohio)
Barriers to measurements 
PHPs encountered some difficulties in measuring prog-
ress or success of interventions. Among these were a 
lack of resources for gathering necessary data, goals that 
proved too ambitious, and variation in physician behavior. 
Informants said they sometimes had problems with their 
computer systems. Some said that entering new patient 
data skewed all previously entered measurement data, 
making it difficult to evaluate improvements over time. 
They also said the lack of standardized codes for labora-
tory tests or other procedures sometimes made it difficult 
to merge data from different sources.
Costs of interventions 
When asked to estimate the financial costs of their PES 
interventions, PHP informants sometimes had difficulty 
assigning a total monetary value to the interventions. This 
was because many components of the interventions were 
phased in over a period of time, and others were incorpo-
rated into regular staff duties:
It’s really hard to answer that because it [the inter-
vention] becomes part of everybody’s work and it 
becomes embedded into the activities across the 
entire spectrum of the organization. (informant, 
Partners for Better Health of Health Partners)
The costs of interventions included personnel time and 
resources devoted to planning and goal setting, imple-
mentation of the interventions, and ongoing activities to 
sustain the interventions. Some interventions involved 
significant time and effort for many people throughout the 
organization, often incurring substantial expenditures as 
measured by decreased time to devote to other services.
One informant described the many variables that could 
affect the cost of setting up a lipid clinic:
The [lipid] clinic costs are dependent on how they 
[are] set up. . . . The cost of putting in a system 
depends on what you’re doing. If you’re putting in 
a paper system, it costs almost nothing. If you put 
in a computer system, it can cost several thousand 
dollars per physician. (informant, Midwest Heart 
Specialists)
Some PHPs attempted to estimate the cost for certain 
components of their interventions. For example, the 
costs ranged from $10,000 to $15,000 for a pharmacy- 
managed lipid clinic to $700,000 for an automated medi-
cal records system with physician reminders for a patient 
population of approximately 300,000. Robeson Healthcare 
Corporation expressed the opinion that interventions were 
worth the cost if they ultimately prevented heart attacks, 
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strokes, and intensive hospitalizations. Midwest Heart 
Specialists developed a virtual computer-based lipid clinic 
to help reduce costs associated with its more intensive 
nurse-managed lipid clinic.
Some informants said that the PES interventions, once 
implemented, actually increased productivity and freed 
up time for physicians and other staff. For some interven-
tions, the costs were offset by help from other resources. 
For example, some PHPs received funds through special 
funding grants for intervention start-up costs. Health 
insurance companies enabled other interventions by reim-
bursing intervention services or by allowing their mem-
bers to have access to intervention programs. Because of 
their proven success with interventions, some PHPs have 
been able to negotiate better health insurance reimburse-
ment rates for intervention-related services.
Lessons learned and recommendations 
Key informants from the PHPs offered numerous recom-
mendations to those interested in implementing similar 
interventions.
Design and implementation of interventions 
• Generate awareness of the intervention among the staff, 
community (when applicable), and other stakeholders.
• Assure that all the stakeholders’ visions for the inter-
vention program are in alignment.
• Plan and organize details of the implementation, includ-
ing resources that will be needed.
• Develop a system for the performance of work processes 
and integrate these processes into the work flow for 
delivering health services. Coordinate the operations 
among all the departments in the organization that will 
be involved with the interventions.
• Start small and persist; do not let desire for perfection be 
a stumbling block.
• Plan to sustain the interventions, which should include 
ongoing training for the staff.
Staffing 
• Get the right people on the health care team:
Pick people [who] are interested and enthusiastic 
to start with; don’t go for your toughest nuts first. 
(informant, Mayo Clinic)
• Interact with staff and other key players to communi-
cate how the protocols will work.
• Listen to and understand the needs of staff involved in 
implementing the interventions.
• Delegate work responsibilities to members of the health 
care team:
Get everyone on the team working at their maxi-
mum level. (informant, Mayo Clinic)
Patient focus 
• Provide patient education with a focus on changing 
behaviors:
It’s really working with people where they are 
and moving them along the continuum from  
inaction to actually taking action. (informant, 
Health Management Corporation/BCBS)
• Foster relationships with patients:
[B]ecause it doesn’t matter if you’re really intel-
ligent; if you can’t communicate well with the 
patient and be congenial, friendly, and likable, then 
it’s not going to work well. The patient is not going 
to follow what you say. I think that’s what has 
helped patients be compliant, is having someone 
that’s very caring and really concerned about them. 
(informant, Drug Therapy Management, Inc)
Discussion
On the basis of these case studies and reported outcome 
data, we concluded that practices that use comprehensive 
systems of patient care can be effective in controlling high 
blood pressure and high cholesterol. The PES interventions 
included 1) automated physician reminder systems, 2) spe-
cialized lipid clinics, 3) collaboratives, and 4) disease man-
agement programs. The common thread for these interven-
tions is that they all incorporated comprehensive systems 
for patient care with processes that were well-defined, 
measurable, and linked to desirable patient outcomes. 
Most relied on data systems to identify patients targeted 
for the interventions and areas in need of improvement 
and to track progress. Most of them also included elements 
of the Chronic Care Model, and some said they used PDSA 
cycles to measure the effectiveness of each step of change.
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Factors critical to success of interventions included sup-
port for patient self-management and education, interven-
tions integrated easily into the daily work flow to make 
it easier for staff to implement them, and leadership 
and staff commitment. Other important factors included 
involving staff throughout the organization and commu-
nity groups in the planning and implementation stages, 
effective communication with health care providers and 
other staff, having ongoing training of staff, and keeping 
the intervention project high on the agenda so that moti-
vation for sustaining it would not be lost. Many of the key 
informants also noted the importance of enlisting the right 
people to be on the intervention team.
These PES interventions may not be applicable to all 
health care settings. Indeed, we note that the 9 PHPs we 
studied were often affiliated with larger health care plans 
that could afford these sometimes costly interventions. 
Smaller health care practices may not have the necessary 
resources.
Limitations and strengths of the case method 
Although most of the PHPs studied relied on noncon-
trolled evaluations, 4 of them used experimental or quasi-
experimental designs to evaluate the PES interventions. 
Although all of the information and data for this article 
were gathered through an interview process, 4 of the 
practices also reported their outcome data for high blood 
pressure and high cholesterol control in 5 studies in the 
peer-reviewed literature (32,33,54,55,64). We identified 
common factors among the PHPs that contributed to 
their success in implementing the interventions, but this 
information was based on only 9 practices. Furthermore, 
our case method did not allow us to determine which PES 
interventions or combinations of interventions were most 
effective. We recommend a meta-analysis of PES interven-
tions in the literature.
Recommendations 
Further research is needed to evaluate the effective-
ness of various PES interventions and to determine how 
smaller health care practices can adopt them. In addition, 
research is needed to determine the actual costs of put-
ting these systems in place and their impact on improving 
health conditions. Many informants were not aware of 
the total costs of implementation. Health care executives 
may be hesitant to initiate similar interventions in their 
practices if the return on investment is uncertain. Studies 
are also needed to determine whether PES interventions 
can sustain positive patient outcomes, avert or delay heart 
disease or stroke, and improve patients’ health, quality of 
life, and productivity.
Conclusion 
The 9 PHPs we studied that used and institutionalized 
PES interventions for at least 1 year reported positive 
outcomes for controlling high blood pressure and high 
cholesterol. We are among the first to use case studies to 
synthesize the practical experiences, lessons learned, and 
recommendations of PHPs using a variety of PES inter-
ventions. These results verify the value of PES interven-
tions reported in the literature, and they have important 
implications for clinicians and for policy makers. The 
results show clinicians that certain strategies and factors 
are critical for establishing comprehensive systems of care, 
which can lead to positive patient outcomes. Policy makers 
may want to consider initiatives that require health care 
practices to adopt these systems of care.
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Table
Table. Policy, Environmental, and Systems-Level Interventions Implemented for Blood Pressure and Cholesterol Control 
Reported by Key Informants at 9 Health Care Practices, 2003a
Intervention KP DTM MHS Mayo RHC LHS HP HMC/BCBS MVP
Disease management program             • • •
Participation in collaborative       • • •      
Specialized lipid clinics   • •            
Automated physician reminders •   •   •        
Electronic medical records •   •         •  
National guidelines • • • • • • • • •
Patient education and self-management goals   • • • • • • • •
Nurse telephone lines     •     • • • •
Treatment protocols or algorithms   • •            
Patient tracking system or registry • • •   • • • • •
Patient flow sheets   • • • •        
Appointment reminders • • •           •
Multidisciplinary team     • • • •   •  
Progress reports or report cards     •   • • •   •
Chronic care model       • • • •    
Plan-Do-Study-Act cycles       • •   •    
Care delivery redesign     • • •        
 
KP indicates Kaiser Permanente, Cleveland, Ohio; DTM, Drug Therapy Management, Inc, Greensboro, North Carolina; MHS, Midwest Heart Specialists, 
Chicago and Rockford, Illinois; Mayo, Mayo Clinic, Division of Community Internal Medicine, Department of Medicine, Rochester, Minnesota; RHC, Robeson 
Healthcare Corporation, Lumberton, North Carolina; LHS, Laurel Health System, Wellsboro, Pennsylvania; HP, Health Partners Health Plan/Disease 
Management Program, Minneapolis, Minnesota; HMC/BCBS, Health Management Corporation, Richmond, Virginia/Blue Cross Blue Shield Delaware, 
Wilmington, Delaware; MVP, MVP Health Care, Schenectady, New York and Williston, Vermont. 
a Data were collected through telephone interviews with key informants (physicians, other health care practitioners, and administrators) at  participating 
health care organizations.
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Outcomes of case study interviews with key informants for  health care 
practices were reported in studies published from 12 through 2002 and 
identified through a literature review by the authors (32,33,5,55,). 
Key informants at  health care organizations were interviewed in 2003. 
Following is a summary of these interviews arranged by intervention.
Automated Physician Reminder Systems Integrated Into 
Electronic Medical Records 
Practice: Kaiser Permanente, Cleveland, Ohio
Outcomes reported: Intervention group resulted in statistically significant 
improvement in cholesterol outcomes (). Study design was nonexperi-
mental; repeat cross-sectional design-time series.
Interview comment: 
“[T]here was better control of cholesterol levels in heart disease patients 
after we turned on [physician] reminders. . . . [At the end of 2001, there 
was] a 0% increase in cholesterol control. . . . [W]e’ve seen improvement 
in low-density lipoprotein (LDL) screening and control.”
Specialized Lipid Clinics 
Practice: Drug Therapy Management, Inc, Greensboro, North 
Carolina 
Outcomes reported: Intervention group resulted in statistically and clinical-
ly significant improvement in cholesterol outcomes compared with control 
group (33). Study design was quasi-experimental.
Interview comment: 
“[T]here are about 500 patients in the study. . . . [A]bout 3% [met] their 
LDL goal levels of less than 100 [mg/dL]. . . . So it’s been very successful.”
Practice: Midwest Heart Specialists, Chicago and Rockford, 
Illinois 
Nurse-Managed Lipid Clinic
Outcomes reported: Intervention group resulted in clinically significant 
improvement in cholesterol outcomes compared with control group (5). 
Study design was quasi-experimental.
Interview comment: 
“Following the initial evaluation, 71% of patients in the lipid clinic were at 
LDL goal, versus 22% of patients at LDL goal in the rest of the cardiology 
practice, and 11% of patients at goal in general practices throughout the 
country (at that time).”
Virtual Lipid Clinic
Outcomes reported: Intervention group resulted in clinically and statisti-
cally significant improvement in cholesterol outcomes compared with con-
trol group (55). Study design was experimental, with randomized selection 
of patients for intervention and control groups.
Interview comments:
“[L]ed to much higher quality patient care on a much more consistent basis 
practice-wide . . . very effective to a much larger group of patients.”
“Approximately 0% of patients are at LDL goal throughout the practice, 
including nurse-managed and virtual lipid clinics.”
Participation in Collaboratives 
Practice: Mayo Clinic, Division of Community Internal 
Medicine, Department of Medicine, Rochester, Minnesota 
Outcomes reported: Intervention group resulted in clinically and statisti-
cally significant improvement in outcomes for blood pressure (32). Study 
design was experimental.
Interview comments:
“We showed fairly consistently about a 5% difference in control rates 
between physicians using this model and physicians not using this model.”
“[W]e’ve seen sort of a sustained improvement in our control rates at least 
for the 3 or so initial years of this study. I think we went somewhere from 
about a baseline of 30% to somewhere up in about the 5% range.”




“Some of the more promising results of the collaborative are improve-
ment in the outcome measure of having blood pressure under control and 
improvements in self-management goal setting. Currently [2003], in our 
self-management goal setting for the cardiovascular registry . . . about  
3% of our [population of focus] has had a self-management goal set.  
. . . [On] the spread population, 35% of 3000 people have had a 
Appendix. Intervention Outcomes and Interview Comments, Case Study of 9 Health Care 
Practices, 2003
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self-management goal set. And that was something that 3 years ago we 
were not doing at all.”
In population of focus of 12 people during a period of 3 years, “5% of 
those people have a blood pressure under 10/0. I think the national 
average is around 20%, and we have been as high as 57%, which is 
almost 3 times that national average. And so that outcome measure, we 
have sustained that.”
“[I]f you look at our spread population, right now, we’re at 32% of 3000 
people . . . who have a blood pressure under control of 10/0. That 
number has been as high as 2%, but that was back when we had 1000 
people in the registry. So we’ve steadily climbed from [about] 15% up to 
32% over the last year while maintaining over 3000 people in that registry.”
Practice: Laurel Health System, Wellsboro, Pennsylvania 
Outcomes not published
Interview comments:
“[O]ne of our goals was [getting] patients’ blood pressure under 10/0 
mm Hg. The national goal is 50%. Right now we are at about 0% of our 
[population of focus] that have made goal.”
“[O]ur latest data [show that] we have 31 patients in the cardiovascular 
registry in that health center and approximately 0% are at goal, whereas 
the spread [population] is 1783, and they are a little over 50% [at goal], so 
their total is close to 50%.”
Disease Management Programs 




“[W]e’ve seen a significant shift toward comprehensive care. . . . [A]re 
they getting their blood pressure in control and do they also have their lipid 
levels not only done but in control, and we’re actually measuring based on 
that whole picture and not just one component of that for a person. So we 
think best care equals having all of that done, and so it has gone up in the 
last few years, but it certainly has a long way to go.”
Practice: Health Management Corporation, Richmond, 




“[H]ealth status and health process measures like getting the testing and 
the results, we see over time improvements in those areas. For example, 
the LDL testing which for diabetics should occur annually, over the course 
of 2 years that will typically shoot up, and meanwhile the value of the LDL, 
which you want to decrease, goes down. So those kinds of measures, we’re 
seeing improvement.”
“[We’ve seen] improvement in medication compliance.”
“We also do the SF-12 and the scores vary somewhat due to the condi-
tions as far as between mental health and the physical components. We’ll 
sometimes see more improvement in the mental health component with 
some conditions that are typically chronic, i.e., congestive heart failure.”
“[W]e also measure, where it’s appropriate, days of . . . lost activity, and 
we’ll see those drop pretty significantly over time.”
“[We’ve seen a] decrease in inpatient admission and inpatient hospital 
days, an increase in pharmacy utilization, a decrease in [emergency room] 
usage . . . there are usually significant cost savings.”




“[Comparisons of] members who were in the program in the first half of 
2002 to those who were not [show] that of people in the program, 0.% 
had an LDL test within the year following their [hospital] discharge [versus] 
80.1% of those not in the program.”
